aripiprazole has been researched along with leptin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, T; Usubiaga, H; Winsberg, B | 1 |
| Bogers, JP; Starrenburg, FC | 1 |
| Alshehabi, E; Rickels, K; Rickels, MR; Teff, KL | 1 |
| Demlova, R; Drazanova, E; Horska, K; Karpisek, M; Kasparek, T; Kotolova, H; Ruda-Kucerova, J | 1 |
| Gorczyca, P; Kunert, Ł; Rykaczewska-Czerwińska, M; Sobiś, J; Świętochowska, E | 1 |
| Choi, SY; Jang, S; Kim, DG; Kim, J; Kim, S; Lee, CH; Lee, KW; Lee, N; Park, JK; Suh, SB | 1 |
1 review(s) available for aripiprazole and leptin
| Article | Year |
|---|---|
How can antipsychotics cause Diabetes Mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins.
Topics: Adiponectin; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Clozapine; Diabetes Mellitus; Humans; Leptin; Obesity; Olanzapine; Piperazines; Quinolones; Receptor, Muscarinic M3; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Receptors, Histamine; Serotonin 5-HT1 Receptor Agonists; Thiazoles; Weight Gain | 2009 |
1 trial(s) available for aripiprazole and leptin
| Article | Year |
|---|---|
Ghrelin and leptin response to oral glucose challenge among antipsychotic drug-treated children.
Topics: Administration, Oral; Adolescent; Age Factors; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Blood Glucose; Body Mass Index; Child; Chlorpromazine; Fasting; Female; Ghrelin; Glucose; Glucose Tolerance Test; Humans; Insulin; Leptin; Male; Piperazines; Quinolones; Risperidone; Sex Factors; Time Factors; Weight Gain | 2007 |
4 other study(ies) available for aripiprazole and leptin
| Article | Year |
|---|---|
Metabolic Impairments Precede Changes in Hunger and Food Intake Following Short-Term Administration of Second-Generation Antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Eating; Ghrelin; Humans; Hunger; Leptin; Metabolic Diseases; Olanzapine; Postprandial Period; Satiety Response; Time Factors | 2015 |
Aripiprazole-induced adverse metabolic alterations in polyI:C neurodevelopmental model of schizophrenia in rats.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Aripiprazole; Body Weight; Cytokines; Disease Models, Animal; Ghrelin; Glucagon-Like Peptide 1; Leptin; Male; Metabolic Syndrome; Poly I-C; Random Allocation; Rats, Wistar; Schizophrenia | 2017 |
The effect of aripiprazole on leptin levels of patients with chronic schizophrenia and a comparison of leptin, acute phase protein, and cytokine levels with regard to body mass and body composition indexes.
Topics: Acute-Phase Proteins; Aripiprazole; Body Composition; Body Mass Index; Cytokines; Female; Humans; Leptin; Male; Schizophrenia | 2022 |
Metformin ameliorates olanzapine-induced disturbances in POMC neuron number, axonal projection, and hypothalamic leptin resistance.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Female; Hypothalamus; Leptin; Metformin; Mice; Neurons; Obesity; Olanzapine; Pro-Opiomelanocortin | 2022 |